AQST
Aquestive Therapeutics Inc
4.60$
-1.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.4% | 59.8% | 31.6% | 29.6% | 31.1% | 38.7% | 28.3% | 29.5% | 40.7% | 41.2% | 31.0% | 38.5% | |
| 39.6% | 40.2% | 68.4% | 70.4% | 68.9% | 61.3% | 71.7% | 70.5% | 59.3% | 58.8% | 69.0% | 61.5% | |
| 59.3% | 73.4% | 29.8% | 33.1% | 34.3% | 39.1% | 43.4% | 33.5% | 36.7% | 25.9% | 35.2% | 38.6% | |
| 347.2% | 416.1% | 40.2% | 37.5% | 107.2% | 122.3% | 121.9% | 105.2% | 110.9% | 62.8% | 87.2% | 179.3% | |
| 466.9% | 549.2% | 70.0% | 70.6% | 141.4% | 161.4% | 165.3% | 138.7% | 147.6% | 88.7% | 122.4% | 217.8% | |
| -366.9% | -449.2% | -1.6% | -0.2% | -72.6% | -100.1% | -93.6% | -68.2% | -88.2% | -29.9% | -53.5% | -156.4% | |
| 0.0% | 0.0% | 11.9% | 11.5% | 11.4% | 17.7% | 28.4% | 44.2% | 26.1% | 14.8% | 29.2% | 38.4% | |
| -390.2% | -469.7% | -18.5% | -13.4% | -91.0% | -125.9% | -121.7% | -138.8% | -114.1% | -15.1% | -76.7% | -188.1% | |
| 0.0% | 0.0% | 11.7% | 11.5% | -7.0% | 12.2% | 20.9% | 38.4% | 12.1% | 0.5% | 0.0% | – | |
| -390.2% | -469.7% | -18.5% | -13.4% | -91.0% | -125.9% | -121.7% | -138.8% | -114.1% | -15.6% | -76.7% | -188.1% | |
| – | – | 5.7% | 3.8% | -74.6% | -102.4% | -85.4% | -88.8% | -83.0% | 2.3% | -46.2% | -148.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.